David Katz Abb Vie Inc. Transaction History

Matrix Asset Advisors Inc

  • $1.02 Billion
  • Q3 2025

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Abb Vie Inc. stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 38,813 shares of ABBV stock, worth $9.08 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
38,813
Previous 38,511 0.78%
Holding current value
$9.08 Million
Previous $7.15 Million 25.71%
% of portfolio
0.88%
Previous 0.77%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
BUY
$184.85 - $231.54 $55,824 - $69,925
302 Added 0.78%
38,813 $8.99 Million
Q2 2025

Jul 25, 2025
SELL
$170.16 - $206.27 $103,457 - $125,412
-608 Reduced 1.55%
38,511 $7.15 Million
Q1 2025

Apr 22, 2025
SELL
$169.2 - $216.66 $11 Million - $14.1 Million
-64,910 Reduced 62.4%
39,119 $8.2 Million
Q4 2024

Jan 22, 2025
BUY
$164.99 - $203.87 $456,692 - $564,312
2,768 Added 2.73%
104,029 $18.5 Million
Q3 2024

Oct 10, 2024
SELL
$163.84 - $199.33 $7.21 Million - $8.77 Million
-43,986 Reduced 30.28%
101,261 $20 Million
Q2 2024

Jul 15, 2024
BUY
$154.79 - $180.76 $354,623 - $414,121
2,291 Added 1.6%
145,247 $24.9 Million
Q1 2024

Apr 15, 2024
SELL
$159.82 - $182.1 $3.43 Million - $3.91 Million
-21,471 Reduced 13.06%
142,956 $26 Million
Q4 2023

Jan 24, 2024
BUY
$137.6 - $154.97 $430,000 - $484,281
3,125 Added 1.94%
164,427 $25.5 Million
Q3 2023

Oct 12, 2023
BUY
$133.59 - $154.65 $42,748 - $49,488
320 Added 0.2%
161,302 $24 Million
Q2 2023

Jul 18, 2023
BUY
$132.51 - $164.9 $393,819 - $490,082
2,972 Added 1.88%
160,982 $21.7 Million
Q1 2023

Apr 13, 2023
SELL
$144.61 - $166.54 $64,929 - $74,776
-449 Reduced 0.28%
158,010 $25.2 Million
Q4 2022

Jan 19, 2023
SELL
$138.31 - $165.87 $587,125 - $704,118
-4,245 Reduced 2.61%
158,459 $0
Q3 2022

Oct 24, 2022
BUY
$134.21 - $153.93 $1.97 Million - $2.25 Million
14,646 Added 9.89%
162,704 $21.8 Million
Q2 2022

Jul 15, 2022
SELL
$137.62 - $174.96 $4.24 Million - $5.39 Million
-30,824 Reduced 17.23%
148,058 $22.7 Million
Q1 2022

Apr 22, 2022
SELL
$131.98 - $163.75 $7.18 Million - $8.9 Million
-54,381 Reduced 23.31%
178,882 $29 Million
Q4 2021

Feb 10, 2022
BUY
$107.43 - $135.93 $16,759 - $21,205
156 Added 0.07%
233,263 $31.6 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $194,180 - $220,423
1,825 Added 0.79%
233,107 $25.1 Million
Q2 2021

Aug 16, 2021
BUY
$105.21 - $117.21 $2,314 - $2,578
22 Added 0.01%
231,282 $26.1 Million
Q1 2021

May 13, 2021
BUY
$102.3 - $112.62 $352,832 - $388,426
3,449 Added 1.51%
231,260 $25 Million
Q4 2020

Feb 12, 2021
BUY
$80.49 - $108.67 $353,029 - $476,626
4,386 Added 1.96%
227,811 $24.4 Million
Q3 2020

Nov 12, 2020
SELL
$85.91 - $100.83 $3.29 Million - $3.86 Million
-38,261 Reduced 14.62%
223,425 $19.6 Million
Q2 2020

Aug 13, 2020
SELL
$73.37 - $98.18 $521,073 - $697,274
-7,102 Reduced 2.64%
261,686 $25.7 Million
Q1 2020

May 11, 2020
SELL
$64.5 - $97.79 $18.3 Million - $27.7 Million
-283,110 Closed
0 $0
Q4 2019

Feb 11, 2020
SELL
$72.13 - $90.25 $67,802 - $84,835
-940 Reduced 0.33%
283,110 $25.1 Million
Q3 2019

Nov 12, 2019
BUY
$62.98 - $75.72 $3.03 Million - $3.64 Million
48,040 Added 20.36%
284,050 $21.5 Million
Q2 2019

Aug 14, 2019
SELL
$65.7 - $83.98 $845,033 - $1.08 Million
-12,862 Reduced 5.17%
236,010 $17.2 Million
Q1 2019

May 10, 2019
BUY
$77.14 - $90.79 $96,116 - $113,124
1,246 Added 0.5%
248,872 $20.1 Million
Q4 2018

Feb 12, 2019
SELL
$77.85 - $96.01 $16,192 - $19,970
-208 Reduced 0.08%
247,626 $22.8 Million
Q3 2018

Nov 13, 2018
BUY
$88.91 - $98.84 $36,097 - $40,129
406 Added 0.16%
247,834 $23.4 Million
Q2 2018

Aug 13, 2018
SELL
$89.78 - $106.23 $197,964 - $234,237
-2,205 Reduced 0.88%
247,428 $22.9 Million
Q1 2018

May 15, 2018
SELL
$92.01 - $123.21 $353,226 - $473,003
-3,839 Reduced 1.51%
249,633 $23.6 Million
Q4 2017

Feb 13, 2018
SELL
$89.56 - $98.21 $666,774 - $731,173
-7,445 Reduced 2.85%
253,472 $24.5 Million
Q3 2017

Nov 14, 2017
SELL
$69.85 - $89.22 $60,350 - $77,086
-864 Reduced 0.33%
260,917 $23.2 Million
Q2 2017

Aug 09, 2017
SELL
N/A
-210 Reduced 0.08%
261,781 $19 Million
Q1 2017

May 10, 2017
SELL
N/A
-680 Reduced 0.26%
261,991 $17.1 Million
Q4 2016

Feb 08, 2017
BUY
N/A
90,091 Added 52.2%
262,671 $16.4 Million
Q3 2016

Nov 07, 2016
BUY
N/A
36,110 Added 26.46%
172,580 $10.9 Million
Q2 2016

Aug 03, 2016
BUY
N/A
59,269 Added 76.77%
136,470 $8.45 Million
Q1 2016

May 05, 2016
BUY
N/A
15,855 Added 25.85%
77,201 $4.41 Million
Q4 2015

Feb 08, 2016
BUY
N/A
61,346 New
61,346 $3.63 Million
Q3 2015

Nov 10, 2015
SELL
N/A
-3,234 Closed
0 $0
Q2 2015

Aug 07, 2015
BUY
N/A
3,234 New
3,234 $217,000
Q1 2015

May 08, 2015
SELL
N/A
-3,234 Closed
0 $0
Q4 2014

Feb 10, 2015
BUY
N/A
3,234
3,234 $212,000

Others Institutions Holding ABBV

# of Institutions
4,480
Shares Held
1.28B
Call Options Held
17.1M
Put Options Held
15.4M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track David Katz's Portfolio

Track David Katz Portfolio

Follow David Katz (Matrix Asset Advisors Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email